Sichuan Gooddoctor Pharmaceutical Co.

China

Sichuan Gooddoctor Pharmaceutical Co.

China
SEARCH FILTERS
Time filter
Source Type

Yang T.,University of Sichuan | Chen J.-X.,University of Sichuan | Fu Y.,University of Sichuan | Chen K.,Sichuan Gooddoctor Pharmaceutical Co. | And 4 more authors.
Organic Process Research and Development | Year: 2014

A concise, environmentally benign, and cost-effective route was developed for the large-scale preparation of 1, a novel oxazolidinone antibacterial candidate. The key intermediate 2-(1-(2-fluoro-4-nitrophenyl)-1H-pyrazol-4-yl) pyridine 7 was prepared with high purity by mild deamination of the regioisomeric mixture 21. The mixture was prepared from a nucleophilic SNAr reaction by selective C-N coupling of the secondary amine functionality of 4-(pyridin-2-yl)-1H-pyrazol-3-amine 14 with 1,2-difluoro-4-nitrobenzene 10 in optimized conditions with the primary amine group remaining intact. The gaseous nitrogen release rate and reaction mixture temperature of the deamination step can be well controlled by altering the feeding manner, thereby providing safety guarantees. The optimized synthetic strategy of 1 with an overall yield of 27.6%, including seven sequential transformations by only five solid-liquid isolations, significantly improved the product separation workup. The strategy bypassed time-consuming and laborious procedures for any intermediate involved as well as for the final API. This study presents a process enabling the rapid delivery of a multikilogram quantity of API with high purity. © 2014 American Chemical Society.

Loading Sichuan Gooddoctor Pharmaceutical Co. collaborators
Loading Sichuan Gooddoctor Pharmaceutical Co. collaborators